Medically reviewed by Mary Choy, PharmD Hydroxyzine is a commonly prescribed antihistamine medication for anxiety and ...

Discussion We showed that QT interval was affected by all immunosuppressive drugs. However, QTc interval prolongation was less prominent in patients on tacrolimus in comparison to other drugs. QTc ...

Monitra Health's patented technology promises to redefine ambulatory ECG monitoring, particularly for conditions like atrial fibrillation and other cardiac arrhythmias and QT prolongation monitoring ...

RESEARCH TRIANGLE PARK, N.C., Nov. 18, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BCRX) today announced that the Health Services ...

The biggest use for hydroxychloroquine is to treat or prevent malaria, a serious and potentially deadly parasitic infection ...

Syndax Pharmaceuticals Inc. won U.S. FDA approval – the company’s second this year – for menin inhibitor Revuforj (revumenib) with a black box warning for differentiation syndrome. “We’ve long ...

Aurinia Pharmaceuticals Inc. (Aurinia or the Company) commends the American College of Rheumatology (ACR) for their 2024 evidence-based guidelines for the screening, treatment, and management of lupus ...

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Syndax ...

The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.

Mizuho Securities analyst Salim Syed has maintained their bullish stance on SNDX stock, giving a Buy rating yesterday.Don't Miss our Black ...

The US Food and Drug Administration has approved revumenib (Revuforj — Syndax Pharmaceuticals) for relapsed or refractory ...